社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
康方生物(09926)
105.300
+1.600
+1.54%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
康方生物
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.akesobio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
康方生物科技（开曼）有限公司是一家致力于研究、开发、生产及商业化让全球病人可负担的抗体药的投资控股公司。该公司在研项目涵盖肿瘤、自身免疫及代谢性疾病等多个领域。该公司的产品主要包括有用于肿瘤领域的开坦尼（卡度尼利，PD-1/CTLA-4）、依达方（依沃西，PD-1/VEGF）、莱法利（AK117，CD47）、普络西（AK109，VEGFR-2）、安尼可（派安普利，PD-1）、科泰莱（塔戈利单抗，PD-L1）和用于代谢及自免领域的伊喜宁（伊努西单抗，PCSK9）、爱达罗（依若奇单抗，IL-12/IL-23）、古莫奇单抗（AK111，IL-17）。
2025-09-30
半年度报告
2025 中期报告
2025 中期报告
2025-09-04
股份发行
完成根据一般授权配售新股及配售现有股份
完成根据一般授权配售新股及配售现有股份
2025-08-28
股份发行
根据一般授权配售新股及配售现有股份
根据一般授权配售新股及配售现有股份
2025-08-26
半年度报告
截至2025年6月30日止六个月中期业绩公告
截至2025年6月30日止六个月中期业绩公告
2025-06-08
股份购回
建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议续聘核数师；及股东周年大会通告
建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议续聘核数师；及股东周年大会通告
2025-04-29
年度报告
2024 年报
2024 年报
2025-03-30
年度报告
截至2024年12月31日止年度业绩公告
截至2024年12月31日止年度业绩公告
2024-10-21
股份发行
完成根据一般授权配售新股
完成根据一般授权配售新股
2024-10-13
股份发行
根据一般授权配售新股
根据一般授权配售新股
2024-09-30
半年度报告
2024 中期报告
2024 中期报告
2024-08-28
半年度报告
截至2024年6月30日止六个月中期业绩公告
截至2024年6月30日止六个月中期业绩公告
2024-06-06
股份购回
建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议修订2021年受限制股份单位计划；建议修订购股权计划；建议续聘核数师；及股东周年大会通告
建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议修订2021年受限制股份单位计划；建议修订购股权计划；建议续聘核数师；及股东周年大会通告
2024-04-29
年度报告
2023 年报
2023 年报
2024-03-28
股份发行
完成根据一般授权配售新股
完成根据一般授权配售新股
2024-03-21
股份发行
根据一般授权配售新股
根据一般授权配售新股
加载更多
分时
5日
日
周
月
数据加载中...
最高
105.600
今开
102.200
量比
0.59
最低
102.100
昨收
103.700
换手率
0.32%
热议股票
{"pagemeta":{"title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康方生物,09926,康方生物股票,康方生物股票老虎,康方生物股票老虎国际,康方生物行情,康方生物股票行情,康方生物股价,康方生物股市,康方生物股票价格,康方生物股票交易,康方生物股票购买,康方生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康方生物(09926)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康方生物(09926)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"fillings","symbol":"09926","data":{"stockData":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":105.3,"timestamp":1770970089006,"preClose":103.7,"halted":0,"volume":2966226,"delay":0,"changeRate":0.01542912246865954,"floatShares":921000000,"shares":921000000,"eps":-0.604581,"marketStatus":"休市中","change":1.6,"latestTime":"02-13 16:08:09","open":102.2,"high":105.6,"low":102.1,"amount":308857249,"amplitude":0.033751,"askPrice":105.3,"askSize":20000,"bidPrice":105,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":-1.007,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771205400000},"marketStatusCode":7,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":103.7,"openAndCloseTimeList":[[1770946200000,1770955200000],[1770958800000,1770969600000]],"volumeRatio":0.5931990254056584,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"AKS.HK","impliedVol":0.5158,"impliedVolPercentile":0.65},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20224658","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7358FYqSEy","pdf_url":"https://static.tigerbbs.com/b3a4355e62f3441f844fb4cce3f528a7","pub_time":1759220100000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025 中期报告","symbol":"09926","title":"2025 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0930/2025093000778_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-30 16:15","pubTimestamp":1759220100,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20129595","market":"hk","labels":[],"media":"港交所","original_id":"N.HK8GebHrCwp3","pdf_url":"https://static.tigerbbs.com/7c4d8c7f90ad49bba8ea6c6139c9a854","pub_time":1756995360000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股及配售现有股份","symbol":"09926","title":"完成根据一般授权配售新股及配售现有股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0904/2025090402064_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份 / 内幕消息 / 股权出现变动]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-09-04 22:16","pubTimestamp":1756995360,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20079793","market":"hk","labels":[],"media":"港交所","original_id":"N.HKr4G68xxFuH","pdf_url":"https://static.tigerbbs.com/846fc830681c456aa83a80d4e576470d","pub_time":1756339680000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股及配售现有股份","symbol":"09926","title":"根据一般授权配售新股及配售现有股份","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0828/2025082800074_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份 / 内幕消息 / 股权出现变动]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2025-08-28 08:08","pubTimestamp":1756339680,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20060055","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBdb8hm7z4Y","pdf_url":"https://static.tigerbbs.com/7a3933a0e3e549afaa8dd32b148343b1","pub_time":1756210680000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月中期业绩公告","symbol":"09926","title":"截至2025年6月30日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0826/2025082601561_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-26 20:18","pubTimestamp":1756210680,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19749059","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAHnV1yHoNA","pdf_url":"https://static.tigerbbs.com/7354cb4ecb1f4046bc56a7e9deb73aca","pub_time":1749380460000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议续聘核数师；及股东周年大会通告","symbol":"09926","title":"建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议续聘核数师；及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0608/2025060800058_c.pdf","us_notice_code":"通函 - [在股东批准的情况下重选或委任董事 / 一般性授权 / 回购股份的说明函件]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-06-08 19:01","pubTimestamp":1749380460,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19562606","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7qd8HHKNTj","pdf_url":"https://static.tigerbbs.com/30f83bbfc09c418480b393ac2a7e1e10","pub_time":1745916240000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024 年报","symbol":"09926","title":"2024 年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0429/2025042901156_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-29 16:44","pubTimestamp":1745916240,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19320000","market":"hk","labels":[],"media":"港交所","original_id":"N.HK5Rjyw2GWMk","pdf_url":"https://static.tigerbbs.com/45d1d9beb6f8489c890c4592bbed1573","pub_time":1743332580000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度业绩公告","symbol":"09926","title":"截至2024年12月31日止年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0330/2025033000528_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-30 19:03","pubTimestamp":1743332580,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18724609","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGjh2CSH5CF","pdf_url":"https://static.tigerbbs.com/429d8f1d7e4c41b19c58c6457937a361","pub_time":1729517160000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股","symbol":"09926","title":"完成根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/1021/2024102100975_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2024-10-21 21:26","pubTimestamp":1729517160,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18702668","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3KV5phcYjW","pdf_url":"https://static.tigerbbs.com/1a8eb014e8d14aef85a377b9904c50cf","pub_time":1728820320000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股","symbol":"09926","title":"根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/1013/2024101300078_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2024-10-13 19:52","pubTimestamp":1728820320,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18662482","market":"hk","labels":[],"media":"港交所","original_id":"N.HKAS7hx5UD4j","pdf_url":"https://static.tigerbbs.com/08af10c7351c4eb3a8c73e3a60c7c66d","pub_time":1727685960000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024 中期报告","symbol":"09926","title":"2024 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0930/2024093000843_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-30 16:46","pubTimestamp":1727685960,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18541369","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBtG86vDzJF","pdf_url":"https://static.tigerbbs.com/244becb7463e439896391089317a2769","pub_time":1724853360000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年6月30日止六个月中期业绩公告","symbol":"09926","title":"截至2024年6月30日止六个月中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0828/2024082802012_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-08-28 21:56","pubTimestamp":1724853360,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18241534","market":"hk","labels":[],"media":"港交所","original_id":"N.HKADUv5hmf52","pdf_url":"https://static.tigerbbs.com/d92ad7cec54342c3950bc6d3ee66473c","pub_time":1717663260000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议修订2021年受限制股份单位计划；建议修订购股权计划；建议续聘核数师；及股东周年大会通告","symbol":"09926","title":"建议授出发行股份及购回股份之一般授权；建议重选退任董事；建议修订2021年受限制股份单位计划；建议修订购股权计划；建议续聘核数师；及股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0606/2024060600652_c.pdf","us_notice_code":"通函 - [在股东批准的情况下重选或委任董事 / 一般性授权 / 回购股份的说明函件 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2024-06-06 16:41","pubTimestamp":1717663260,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18070602","market":"hk","labels":[],"media":"港交所","original_id":"N.HKB1xUFMbXxy","pdf_url":"https://static.tigerbbs.com/c0fd0367b5e747e491944b7d8ad6f66e","pub_time":1714401000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023 年报","symbol":"09926","title":"2023 年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0429/2024042905684_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-04-29 22:30","pubTimestamp":1714401000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17776358","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCUodBTaKFL","pdf_url":"https://static.tigerbbs.com/968055661a474aba85362c0aae1ce7c4","pub_time":1711629660000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"完成根据一般授权配售新股","symbol":"09926","title":"完成根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0328/2024032803199_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2024-03-28 20:41","pubTimestamp":1711629660,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17732093","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2wytU27oqb","pdf_url":"https://static.tigerbbs.com/4452e19ecd764bcc928638c9077984db","pub_time":1710978960000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"根据一般授权配售新股","symbol":"09926","title":"根据一般授权配售新股","titleType":"股份发行","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0321/2024032100040_c.pdf","us_notice_code":"公告及通告 - [配售 / 根据一般性授权发行股份 / 内幕消息 / 股权出现变动]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Issuance","event_type":"important_notice","event_name":"股份发行","pubTime":"2024-03-21 07:56","pubTimestamp":1710978960,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.akesobio.com","stockEarnings":[{"period":"1week","weight":0.0436},{"period":"1month","weight":-0.1467},{"period":"3month","weight":-0.1136},{"period":"6month","weight":-0.3637},{"period":"1year","weight":0.8787},{"period":"ytd","weight":-0.0681}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.016},{"period":"3month","weight":-0.0187},{"period":"6month","weight":0.0513},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0365}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康方生物科技（开曼）有限公司是一家致力于研究、开发、生产及商业化让全球病人可负担的抗体药的投资控股公司。该公司在研项目涵盖肿瘤、自身免疫及代谢性疾病等多个领域。该公司的产品主要包括有用于肿瘤领域的开坦尼（卡度尼利，PD-1/CTLA-4）、依达方（依沃西，PD-1/VEGF）、莱法利（AK117，CD47）、普络西（AK109，VEGFR-2）、安尼可（派安普利，PD-1）、科泰莱（塔戈利单抗，PD-L1）和用于代谢及自免领域的伊喜宁（伊努西单抗，PCSK9）、爱达罗（依若奇单抗，IL-12/IL-23）、古莫奇单抗（AK111，IL-17）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003338},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016615},{"month":3,"riseRate":0.4,"avgChangeRate":-0.035342},{"month":4,"riseRate":0.8,"avgChangeRate":0.041218},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.003133},{"month":6,"riseRate":0.666667,"avgChangeRate":0.133235},{"month":7,"riseRate":0.5,"avgChangeRate":0.087867},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007754},{"month":9,"riseRate":0.5,"avgChangeRate":0.036209},{"month":10,"riseRate":0.5,"avgChangeRate":0.046029},{"month":11,"riseRate":1,"avgChangeRate":0.102206},{"month":12,"riseRate":0.333333,"avgChangeRate":0.028279}],"exchange":"SEHK","name":"康方生物","nameEN":"AKESO"},"aProfile":null}}}